Overview

Once-a-day Immunosuppression(CISECON_a_day)

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to assess the efficacy and safety and Immunosuppressant Therapy Barrier Scale (ITBS) of once daily immunosuppressant maintenance therapy in patients who had kidney transplantations earlier.

Phase:

Phase 4

Details

Lead Sponsor:

Ajou University School of Medicine